Metabolomic Characterization of Ovarian Epithelial Carcinomas by HRMAS-NMR Spectroscopy

被引:45
作者
Ben Sellem, D. [1 ,2 ]
Elbayed, K. [3 ]
Neuville, A. [4 ]
Moussallieh, F. -M. [1 ,3 ]
Lang-Averous, G. [4 ]
Piotto, M. [3 ,5 ]
Bellocq, J. -P. [4 ]
Namer, I. J. [1 ,2 ]
机构
[1] Univ Hosp Strasbourg, Biophys & Nucl Med Dept, F-67098 Strasbourg, France
[2] Univ Strasbourg, CNRS, LINC, UMR 7237, F-67081 Strasbourg, France
[3] Univ Strasbourg, CNRS, Inst Chem, UMR 7177, F-67081 Strasbourg, France
[4] Univ Hosp Strasbourg, Pathol Dept, F-67098 Strasbourg, France
[5] Bruker BioSpin, F-67160 Wissembourg, France
关键词
D O I
10.1155/2011/174019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives. The objectives of the present study are to determine if a metabolomic study by HRMAS-NMR can (i) discriminate between different histological types of epithelial ovarian carcinomas and healthy ovarian tissue, (ii) generate statistical models capable of classifying borderline tumors and (iii) establish a potential relationship with patient's survival or response to chemotherapy. Methods. 36 human epithelial ovarian tumor biopsies and 3 healthy ovarian tissues were studied using 1H HRMAS NMR spectroscopy and multivariate statistical analysis. Results. The results presented in this study demonstrate that the three histological types of epithelial ovarian carcinomas present an effective metabolic pattern difference. Furthermore, a metabolic signature specific of serous (N-acetyl-aspartate) and mucinous (N-acetyl-lysine) carcinomas was found. The statistical models generated in this study are able to predict borderline tumors characterized by an intermediate metabolic pattern similar to the normal ovarian tissue. Finally and importantly, the statistical model of serous carcinomas provided good predictions of both patient's survival rates and the patient's response to chemotherapy. Conclusions. Despite the small number of samples used in this study, the results indicate that metabolomic analysis of intact tissues by HRMAS-NMR is a promising technique which might be applicable to the therapeutic management of patients.
引用
收藏
页数:9
相关论文
共 47 条
[1]   Choline phospholipid metabolism: A target in cancer cells? [J].
Ackerstaff, E ;
Glunde, K ;
Bhujwalla, ZM .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 90 (03) :525-533
[2]   Concentration measurement by proton NMR using the ERETIC method [J].
Akoka, S ;
Barantin, L ;
Trierweiler, M .
ANALYTICAL CHEMISTRY, 1999, 71 (13) :2554-2557
[3]  
[Anonymous], 1971, Acta Obstet Gynecol Scand, V50, P1
[4]   N-acetylaspartate in the vertebrate brain:: Metabolism and function [J].
Baslow, MH .
NEUROCHEMICAL RESEARCH, 2003, 28 (06) :941-953
[5]   Identification of N-acetylaspartate in the lens of the vertebrate eye: A new model for the investigation of the function of N-acetylated amino acids in vertebrates [J].
Baslow, MH ;
Yamada, S .
EXPERIMENTAL EYE RESEARCH, 1997, 64 (02) :283-286
[6]   Magnetic Resonance Metabolomics of Intact Tissue: A Biotechnological Tool in Cancer Diagnostics and Treatment Evaluation [J].
Bathen, Tone F. ;
Sitter, Beathe ;
Sjobakk, Torill E. ;
Tessem, May-Britt ;
Gribbestad, Ingrid S. .
CANCER RESEARCH, 2010, 70 (17) :6692-6696
[7]   In vivo magnetic resonance spectroscopy of gynaecological tumours at 3.0 Tesla [J].
Booth, S. J. ;
Pickles, M. D. ;
Turnbull, L. W. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2009, 116 (02) :300-303
[8]  
Boss EA, 2000, NMR BIOMED, V13, P297, DOI 10.1002/1099-1492(200008)13:5<297::AID-NBM648>3.0.CO
[9]  
2-I
[10]  
Burlina AP, 1997, J NEUROCHEM, V69, P1314